MedTrace Logo

Antimicrobial Resistance in Acute Cholangitis

NCT06197984 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1435

Last updated 2026-04-28

No results posted yet for this study

Summary

This study prospectively explores antimicrobial resistance in patients with acute cholangitis undergoing ERCP procedures. By analyzing patient profiles, microbial cultures, and treatment outcomes, the current study seeks to identify specific patterns of resistance, assess the effectiveness of current antimicrobial therapies, and explore potential strategies to optimize treatment regimens.

Conditions

  • Cholangitis Acute
  • Biliary Tract Diseases
  • Jaundice; Malignant
  • Jaundice, Obstructive
  • Choledocholithiasis

Interventions

PROCEDURE

ERCP

ERCP will serve as the exclusive therapeutic modality, aided by a therapeutic duodenoscope to access the common bile duct using a guidewire.

Sponsors & Collaborators

  • Carol Davila University of Medicine and Pharmacy

    collaborator OTHER

  • Grigore T. Popa University of Medicine and Pharmacy

    collaborator OTHER

  • Bucharest Emergency Hospital

    collaborator OTHER

  • Emergency County Hospital Pius Brinzeu; Timisoara, Romania

    lead NETWORK

Principal Investigators

  • Bogdan Miutescu, MD,PhD · Emergency County Hospital Pius Brinzeu; Timisoara, Romania

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-01-08
Primary Completion
2026-01-05
Completion
2026-01-05

Countries

  • Romania

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06197984 on ClinicalTrials.gov